https://www.reuters.com/article/us-elililly-alzheimers/lilly-says-alzheimers-drug-slows-clinical-decline-in-mid-stage-trial-idUSKBN29G161...
What type of T cells? By activation you mean they are pumping out cytokines? If so, wouldn’t this have shown up on tests? If there is abnormal T...
This represents your opinion— it was not the conclusion of the authors of the study.
There are a lot of auto-immune diseases that don’t respond to rituximab like type 1 diabetes and lupus. Fluge & Mella believe there is an...
They probably have a biomarker now— my guess! Sounds optimistic. Maybe they figured out the Abilify tolerance thing as well.
Abilify can alter sleep but it sounds like he naturally only sleeps 2 hours per day.
Good article. Abilify I believe. Surprised to hear that Whitney only sleeps 2 hours a day. Seems really bad.
Agree with @Bill—probably not a good idea to subdivide patients with the MECFS syndrome into subgroups based on which symptom is the most...
Correct. I tried to make this same point on a different thread. Plus they are too busy plus there is no incentive for them to conduct...
Maybe Viking HLA genes are different??
https://med.stanford.edu/content/dam/sm/dbds/documents/data-studio/abstract.20201118.pdf Retrospective data analysis of Abilify plus plans for a...
They also need to look at the tachyphlaxis (poop out) mechanism and how to overcome it.
skeptical of this. And this
[MEDIA]
Looks promising— not sure why Pfizer didn’t follow up.
Comments on the above {crappy} NYT article are open now—please make comments about MECFS—thanks.
Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover,...
Separate names with a comma.
